SurgVision Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

SurgVision General Information

Description

Developer of molecular surgical imaging technology designed to discriminate between healthy and cancerous tissue. The company develops intraoperative imaging systems, near-infrared fluorescence devices, targeted imaging agents, clinical validation support, regulatory documentation, and technology platforms for real-time tumor visualization during surgery.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Kistlerhofstr. 70
  • Geb. 79
  • 81379 Munich
  • Germany
+49 089
Primary Industry
Diagnostic Equipment
Parent Company
Vertical(s)
Corporate Office
  • Kistlerhofstr. 70
  • Geb. 79
  • 81379 Munich
  • Germany
+49 089

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SurgVision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 18-Oct-2017 Completed Generating Revenue
2. Early Stage VC 19-Dec-2014 Completed Generating Revenue
1. University Spin-Out 01-Aug-2013 Completed Startup
To view SurgVision’s complete valuation and funding history, request access »

SurgVision Patents

SurgVision Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026510742-A Cooling system for the imaging head of a fluorescence imaging device Pending 14-Mar-2023
EP-4680094-A1 Cooling system of an imaging head of a fluorescence imaging apparatus Pending 14-Mar-2023
WO-2024189097-A1 Cooling system of an imaging head of a fluorescence imaging apparatus Inactive 14-Mar-2023
JP-2026500611-A Motion-corrected background subtraction for fluorescence imaging Pending 30-Dec-2022
EP-4642310-A1 Motion-stabilized background subtraction for fluorescence imaging Pending 30-Dec-2022 A61B1/000095
To view SurgVision’s complete patent history, request access »

SurgVision Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SurgVision Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ascenion Accelerator/Incubator Minority
BioGeneration Ventures Venture Capital Minority
DFZ Participaties Venture Capital Minority
Mibiton Venture Capital Minority
To view SurgVision’s complete investors history, request access »

SurgVision FAQs

  • When was SurgVision founded?

    SurgVision was founded in 2013.

  • Where is SurgVision headquartered?

    SurgVision is headquartered in Munich, Germany.

  • What is the size of SurgVision?

    SurgVision has 8 total employees.

  • What industry is SurgVision in?

    SurgVision’s primary industry is Diagnostic Equipment.

  • Is SurgVision a private or public company?

    SurgVision is a Private company.

  • What is SurgVision’s current revenue?

    The current revenue for SurgVision is .

  • Who are SurgVision’s investors?

    Ascenion, BioGeneration Ventures, DFZ Participaties, and Mibiton have invested in SurgVision.

  • When was SurgVision acquired?

    SurgVision was acquired on 18-Oct-2017.

  • Who acquired SurgVision?

    SurgVision was acquired by Blue Earth Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process